Trial Details

COMPLETED
Basic Information
Clinical ID c4627
Identifier NCT00234741
Trial Title Study of STA-5326 Mesylate in Patients With Moderate to Severe Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Crohn's Disease
Interventions DRUG: STA-5326 mesylate
Participant Information
Sponsor Synta Pharmaceuticals Corp.
City Bethesda
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2005-11
Primary Completion Date -
Completion Date -